Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Accenture
Mallinckrodt
Federal Trade Commission
Chubb
Colorcon
Farmers Insurance
Harvard Business School
Fuji
Daiichi Sankyo

Generated: January 18, 2018

DrugPatentWatch Database Preview

LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN Drug Profile

« Back to Dashboard

When do Lansoprazole, Amoxicillin And Clarithromycin patents expire, and when can generic versions of Lansoprazole, Amoxicillin And Clarithromycin launch?

Lansoprazole, Amoxicillin And Clarithromycin is a drug marketed by Rising Pharms Inc, Sandoz Inc, and Teva Pharms Usa. and is included in three NDAs.

The generic ingredient in LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN is amoxicillin; clarithromycin; lansoprazole. There are forty-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.

US Patents and Regulatory Information for LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising Pharms Inc LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN amoxicillin; clarithromycin; lansoprazole CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 206006-001 Oct 7, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN amoxicillin; clarithromycin; lansoprazole CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 202588-001 Mar 4, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN amoxicillin; clarithromycin; lansoprazole CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 200218-001 Aug 30, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Moodys
Cipla
Federal Trade Commission
UBS
Argus Health
Cerilliant
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot